PetMed Express, Inc. (NASDAQ:PETS) declared a quarterly dividend on Tuesday, October 24th, Wall Street Journal reports. Shareholders of record on Monday, November 6th will be paid a dividend of 0.20 per share on Friday, November 17th. This represents a $0.80 dividend on an annualized basis and a yield of 2.08%. The ex-dividend date of this dividend is Friday, November 3rd.

Shares of PetMed Express (PETS) traded down 11.61% on Tuesday, reaching $38.37. 2,279,111 shares of the company’s stock were exchanged. PetMed Express has a one year low of $18.90 and a one year high of $50.90. The firm has a 50 day moving average of $35.86 and a 200 day moving average of $36.30. The firm has a market capitalization of $778.60 million, a P/E ratio of 29.52 and a beta of 1.03.

PetMed Express (NASDAQ:PETS) last announced its earnings results on Monday, October 23rd. The company reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.30 by $0.13. The business had revenue of $66.70 million for the quarter, compared to analysts’ expectations of $63.41 million. PetMed Express had a net margin of 10.34% and a return on equity of 28.67%. The company’s quarterly revenue was up 9.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.24 EPS. On average, equities research analysts predict that PetMed Express will post $1.44 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “PetMed Express, Inc. to Issue Quarterly Dividend of $0.20 (PETS)” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/10/24/petmed-express-inc-to-issue-quarterly-dividend-of-0-20-pets.html.

In other PetMed Express news, Director Ronald J. Korn sold 5,000 shares of the business’s stock in a transaction on Friday, July 28th. The shares were sold at an average price of $48.18, for a total transaction of $240,900.00. Following the sale, the director now directly owns 67,333 shares in the company, valued at approximately $3,244,103.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Bruce S. Rosenbloom sold 6,833 shares of the business’s stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $50.18, for a total transaction of $342,879.94. Following the sale, the chief financial officer now owns 18,534 shares in the company, valued at $930,036.12. The disclosure for this sale can be found here. Insiders have sold a total of 19,333 shares of company stock worth $949,730 over the last 90 days. Insiders own 4.00% of the company’s stock.

A number of equities analysts have recently commented on the stock. Zacks Investment Research raised shares of PetMed Express from a “sell” rating to a “hold” rating in a report on Friday. Credit Suisse Group reissued an “underperform” rating and issued a $19.00 price objective on shares of PetMed Express in a research note on Monday, October 2nd. ValuEngine cut shares of PetMed Express from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. Craig Hallum reissued a “hold” rating and issued a $40.00 price objective (down from $43.00) on shares of PetMed Express in a research note on Monday, August 21st. They noted that the move was a valuation call. Finally, Noble Financial reissued a “hold” rating on shares of PetMed Express in a research note on Wednesday, July 26th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the stock. PetMed Express presently has an average rating of “Hold” and an average target price of $40.00.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Dividend History for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.